ELUTIA INC.

ELUT · Nasdaq · SIC 2836: Biological Products, (No Diagnostic Substances) · Market Cap: $0.0B · 26 employees
119
SEC Filings
$1.16
Close 2026-05-29
26
Employees

Business Summary

PART I . Overview At Elutia, our mission is to humanize medicine so that patients can thrive without compromise. We develop proprietary drug-eluting biomatrix products for use in surgical reconstruction and related applications. These products are designed to improve the interaction between implanted medical devices and patients. Our focus is on addressing unmet medical needs and reducing complications associated with surgery, including infection, migration, erosion, implant rejection, and fibro...

Latest Stock Quote

ELUT 2026-05-29 $1.16 O:$1.1004 H:$1.18 L:$1.1004 Vol:0.1M VWAP:$1.1484
origin leaf: 7937ac4fb26727c4662850d8b6c98a01665a562c78d095257a76a35b7ac5bc92

Next Earnings

Q2 FY2026 — expected 2026-09-13

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-03-132025-12-310001104659-26-027664EDGAR83K words
2025-03-112024-12-310001558370-25-002719EDGAR
2024-03-112023-12-310001558370-24-002864EDGAR
2023-03-232022-12-310001558370-23-004475EDGAR
2022-03-082021-12-310001558370-22-003073EDGAR
2021-03-152020-12-310001104659-21-036360EDGAR

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2025-11-122025-09-300001104659-25-110492EDGAR36K words
2025-08-142025-06-300001558370-25-011590EDGAR
2025-05-132025-03-310001558370-25-007586EDGAR
2024-11-142024-09-300001558370-24-015748EDGAR
2024-08-132024-06-300001558370-24-011988EDGAR
2024-05-132024-03-310001558370-24-007987EDGAR
2023-11-142023-09-300001558370-23-019057EDGAR
2023-08-142023-06-300001558370-23-014906EDGAR
2023-05-122023-03-310001558370-23-009624EDGAR
2022-11-142022-09-300001558370-22-017842EDGAR
2022-08-152022-06-300001558370-22-013666EDGAR
2022-05-102022-03-310001558370-22-008098EDGAR

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-03-110001104659-26-026398EDGAR4K words
2026-03-090001104659-26-025311EDGAR
2026-03-040001104659-26-023189EDGAR
2026-01-120001104659-26-002742EDGAR
2026-01-020001104659-26-000076EDGAR
2025-11-120001104659-25-109699EDGAR
2025-11-060001104659-25-107741EDGAR
2025-10-140001104659-25-099347EDGAR
2025-10-070001104659-25-097561EDGAR
2025-09-090001104659-25-088481EDGAR

119 total filings indexed. 91 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

FDMT — 4D Molecular Therapeutics, Inc. APTN — ADAPTIN BIO, INC. ADMA — ADMA BIOLOGICS, INC. AGEN — AGENUS INC AIM — AIM ImmunoTech Inc. AMGN — AMGEN INC AVXL — ANAVEX LIFE SCIENCES CORP. ABPO — Abpro Holdings, Inc.

Company Identity

CIK0001708527
TickerELUT
ExchangeNasdaq
SIC2836: Biological Products, (No Diagnostic Substances)
IncorporatedDE
Websitehttps://www.elutia.com
Listed2020-10-08

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: 6d013bfd70136dd587b66221a1933339be344d57a61e782b86bfc5acb4c26c9a
parent: 91fa62b655d9080eb7dfec91d3ee112211429669c1860b5af3f6fb2fc05e76f8
content hash: 6257e8c8e17d279f8106a14ae46bdd22b570e6f9c1afb5835da66d26d5f8fae5
signed: 2026-06-03T12:00:57.683Z
sources: 19 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf